In global medical device and MedTech news from July 6-12, 2026, there were many developments regarding new products, approvals, and market launches, including treatments for atrial fibrillation, surgical assistance robots, AI-powered ultrasound, neurostimulation robots, intubation assistance systems, and vascular access devices for dialysis.
Regarding M&A, the completion of Stereotaxis' acquisition of Robocath, ResMed's sale of MatrixCare, and Corza Medical's sale of its biosurgery business were reported. In safety-related news, recalls and early warning information were issued for infusion pumps, medical kits, and Impella-related devices.
Main News
1. Johnson & Johnson Receives FDA Approval for Atrial Fibrillation Ablation System Integrating RF and PFA
Johnson & Johnson MedTech has received FDA approval for its "ThermoCool SmartTouch SF" platform, which allows for the selective use of radiofrequency (RF) and pulsed field ablation (PFA) with a single catheter.
The system combines an irrigated catheter with a contact force sensor and a TruPulse generator, aiming to enable energy selection tailored to the case and treatment site in atrial fibrillation therapy.
Source: Johnson & Johnson - Dual Energy THERMOCOOL SMARTTOUCH SF Platform FDA Approval
2. Medicaroid Obtains European CE Mark for Surgical Support Robot "hinotori"
Medicaroid has obtained the CE Mark for its domestically developed surgical support robot, "hinotori Surgical Robot System," under the European Medical Device Regulation (EU MDR).
hinotori is a surgical support robot developed in Japan, and this CE Mark acquisition will enable its expansion into the European market. The surgical support robot market is seeing increased competition, with new entrants joining established major players, leading to expanded competition in areas such as price, operability, applicable medical departments, and maintenance systems.
Source: Medicaroid - hinotori Surgical Robot System CE Mark
3. Philips Launches AI-Powered Ultrasound System "Alturion"
Philips has announced "Alturion," a new ultrasound diagnostic system featuring AI-powered workflow support.
Alturion is designed for high-volume healthcare facilities, aiming to standardize examinations, assist with measurements, and reduce operator burden. In ultrasound examinations, image acquisition and measurement results can vary significantly depending on the operator's experience, which is why the introduction of AI-powered support functions is advancing.
Source: Philips - Alturion Ultrasound System
4. Zeta Surgical Receives FDA 510(k) Clearance for TMS Robot
Zeta Surgical has obtained FDA 510(k) clearance for its "TMS Robotic System," used for Transcranial Magnetic Stimulation (TMS).
The system aims to improve the reproducibility of stimulation sites by tracking patient movement in real-time and automatically adjusting the position of the TMS coil. TMS is used to treat conditions such as depression, and robot-assisted positioning has the potential to enhance treatment accuracy and operational efficiency.
Source: Zeta Surgical - TMS Robotic System FDA Clearance
5. Spiro Robotics Receives FDA 510(k) Clearance for Intubation Assistance System
Spiro Robotics has received FDA 510(k) clearance for "Spiro-VISTA," a system designed to assist with tracheal tube placement in adult patients during both routine and difficult airway intubation.
Spiro-VISTA is a handheld, dual-imaging system intended to improve visualization during tracheal intubation. Addressing difficult airways remains a critical challenge in emergency, critical care, and anesthesia settings, and the demand for intubation assistance devices continues.
Source: Spiro Robotics - Spiro-VISTA FDA Clearance
6. Xeltis Initiates European Commercial Use of "aXess" Vascular Access Device for Dialysis
Xeltis has performed the first commercial implantation in Europe of its "aXess" vascular access conduit for hemodialysis.
aXess is a vascular access device designed to gradually replace tissue within the body, promoting the formation of new blood vessels. For dialysis access, both autologous arteriovenous fistulas and synthetic grafts present challenges, making regenerative conduits an 주목される (promising) new option.
Source: Xeltis - aXess Commercial Implantation
7. Jenscare Obtains CE Mark for Transcatheter Tricuspid Valve Replacement System "LuX-Valve Plus"
Jenscare Scientific has obtained CE Mark under the EU MDR for its transcatheter tricuspid valve replacement system, "LuX-Valve Plus," indicated for severe tricuspid regurgitation.
In the tricuspid valve field, the development of transcatheter treatments for patients at high surgical risk is progressing. LuX-Valve Plus is a TTVR system that implants an artificial valve intravascularly without open-heart surgery.
Source: Jenscare - LuX-Valve Plus CE Mark
8. ENvue Medical Announces AI- and Robot-Assisted Nasogastric Tube Placement Device
ENvue Medical has announced "ENvue Drive," a next-generation system designed to assist with nasogastric tube placement.
The system combines real-time guidance, AI, and robot-assisted features to support tube placement at the bedside. Given the challenges of misplacement and position verification with nasogastric tubes, there is growing interest in placement assistance technologies.
Source: ENvue Medical - ENvue Drive Launch
9. Stereotaxis Acquires Robocath, an Endovascular Robotics Company
Stereotaxis has completed the acquisition of Robocath, a company that develops endovascular treatment robots. The acquisition is valued at up to $45 million.
Robocath develops robotic systems to support coronary and peripheral vascular interventions, while Stereotaxis deploys robotic technology in the cardiac electrophysiology field. This acquisition will allow Stereotaxis to expand its robotic technology into the endovascular treatment domain.
Source: Stereotaxis - Robocath Acquisition
10. ResMed to Sell MatrixCare Business for $490 Million
ResMed announced it will sell MatrixCare, a software provider for skilled nursing facilities and home care providers, to Frazier Healthcare Partners for $490 million.
ResMed appears to be focusing its management resources on its core businesses related to sleep apnea and respiratory diseases. Medical device companies continue to review their business portfolios, including digital health and software operations.
Source: ResMed - MatrixCare Sale
11. Neuspera Confirms Medicare Billing Codes for Sacral Neuromodulation System
Neuspera Medical announced that CMS has confirmed the codes used for Medicare billing for its sacral neuromodulation (SNM) system.
Sacral neuromodulation is an implanted neurostimulation therapy used for conditions such as overactive bladder and fecal incontinence. For medical devices, having appropriate billing codes and payment structures in place after approval significantly impacts actual adoption.
Source: Neuspera Medical - Medicare Code Confirmation
12. FDA Updates Recall Information for Infusion Pumps, Medical Kits, and Impella-Related Devices
The FDA has updated its recall and early alert information regarding devices such as Fresenius Kabi's Ivenix Large Volume Infusion Pump, Medical Action Industries' and Medline's medical convenience kits, and Abiomed's Impella CP with SmartAssist Introducer Kit.
Infusion pumps and circulatory support devices are high-risk products critical for life support. Issues with accessories and kit components can also lead to significant safety risks, necessitating continued monitoring of post-market information.
Source: FDA - Medical Device Recalls and Early Alerts
Summary
In medical device and MedTech news from July 6-12, 2026, there was significant activity related to new products and approvals, including J&J's dual-energy atrial fibrillation ablation system, Medicaroid's hinotori European CE Mark, Philips' AI-powered ultrasound diagnostic device, Zeta Surgical's TMS robot, and Spiro Robotics' intubation assistance system.
Additionally, development of minimally invasive, procedure-support, and regenerative devices is progressing, such as Xeltis' vascular access device for dialysis, Jenscare's tricuspid valve replacement system, and ENvue Medical's feeding tube placement assistance device.
In M&A news, Stereotaxis acquired Robocath, and ResMed sold MatrixCare. Regarding safety, recalls and early warning notifications were issued for infusion pumps, medical kits, and Impella-related devices.
This week saw advancements in product commercialization across multiple areas, including medical robotics, AI, cardiovascular treatment, neurostimulation, and dialysis access.